Heather Gessling
Family Medicine · Moberly, MONPI 1639377336
Payments from drug & device makers
Across 444 payments — averaging $13.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$725
- AbbVie$597
- Lilly USA, LLC$574
- Pfizer$448
- Novo Nordisk$437
- Sunovion Pharmaceuticals Inc.$343
- plus $3K from 36 others
What the payments were for
- Speaking & faculty fees$150%
- Food & beverage$6,088100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$120
How this compares
$6,117 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 36 | $52,229 |
| OzempicSemaglutide | 29 | $32,563 |
| EliquisApixaban | 18 | $15,281 |
| Bydureon BciseExenatide Microspheres | 14 | $13,859 |
| PremarinEstrogens, Conjugated | 14 | $3,279 |
| Buprenorphine | 26 | $2,917 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 112 | $1,873 |
| Clonidine | 14 | $1,547 |
| Fluvoxamine Maleate | 27 | $1,444 |
| Levothyroxine Sodium | 157 | $1,334 |
| SynthroidLevothyroxine Sodium | 22 | $1,094 |
| Hydroxychloroquine Sulfate | 42 | $952 |
| Vilazodone Hcl | 12 | $805 |
| Duloxetine Hcl | 44 | $677 |
| Potassium Chloride | 42 | $676 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $574 | $52,22936 claims |
| Novo NordiskOzempic | $437 | $32,56329 claims |
| PfizerEliquis, Premarin | $448 | $18,56032 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $66 | $1,334157 claims |
| AbbVieSynthroid | $597 | $1,09422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Moberly
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.